by Martin Armstrong, Armstrong Economics: Moderna is back at the public trough with another experimental mRNA vaccine, this time targeting the Bundibugyo strain of Ebola. CBC reports that Health Canada has authorized a Phase 1 trial of mRNA-1469 at three Canadian sites involving about 80 adults. Canada has never recorded a single Ebola case, and its government […]